Canine Mammary Tumors - Breed, Age and Malignant Characteristics as Risk Factors

Autores

  • arda selin tunc Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey. https://orcid.org/0000-0002-4813-7626
  • Sevil Atalay Vural Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey.

DOI:

https://doi.org/10.22456/1679-9216.134166

Resumo

Abstract

Background: Canine mammary tumor (CMT) is a benign or malignant neoplasm originating from epithelium, myoepithelium and/or mesenchymal cells of the mammary gland. CMTs are the most often diagnosed neoplasia and age, breed, tumor characterizations as risk factors are important in CMTs. Canine mammary tumors are mostly in the malignant form, not in the benign features. There is a connection between the characters and localizations of the CMT and it frequently occurred in the 3rd, 4th and 5th lobes. These mammary lobes have more malignant characteristics than those in the other lobes, and there is no difference in terms of localization in the right and left lobes This study aimed to identify the variety and the differences occurring of breed, age and tumor characteristics in canine mammary tumors in recent years.

Materials, Methods & Results: A total of 165 mammary tumors from 64 bitches were collected and investigated morphologically and histopathologically. The tumors were usually elastic or hard in consistency. The cut surfaces were homogeneous or lobular in appearance and gray-white in color. Most tumors were hard and difficult to cut, so had gray-white bone-like areas on the cut section the histopathological examination of tumors; benign mixed tumor (n = 7), carcinoma in situ (n = 9), simple carcinoma (n = 22), comedocarcinoma (n = 1), mucinous carcinoma (n = 1), carcinosarcoma (n = 114), squamous cell cancer (n = 4), basal cell cancer (n = 1), lipoma (n = 5), fibrosarcoma (n = 1) were diagnosed  The formation of CMTs especially malignant tumors was mostly in the 9-12 age range (45.31%). According to the breed of other tumors were distributed as follows: Boxer (n = 15), mongrel (n = 9), German Shepherd (n = 7), Cocker Spaniel (n = 6), Poodle (n = 5), Kangal (n = 4), Rottweiler (n = 2) and Golden Retriever (n = 2), unknown breed (n = 11), Pekingese, Russian Poodle and Labrador retriever (n = 1 each). Half of the cases (50%) were Terrier, and it is followed by the mongrel dogs (12.5%). Malignant CMTs were detected in 95% of Terriers (95/101), while 100% were detected in Cocker Spaniel and Mongrel breeds. Although multiple simultaneous tumors in both the right and left mammary lobes (23/64 = 35.94%), CMTs occurred in the 5th mammary lobe with a rate of 15/64 (23.44%). Benign tumors were noticed less frequently (7.2%) in all mammary tumors, while malignant tumors were much more (92.8%). Of these malignant tumors, 13.3% were simple carcinomas and 69.1% were carcinosarcomas. Out of 64 animals, 23 cases (35.94%) had multiple growths and 41 cases (64.06%) had solitary growths. Lymph node metastases were also detected in 13.16% of them; therefore, benign mixed tumors and carcinosarcomas were excluded from grading for similar reasons, and only simple carcinomas were graded. Since the number of subtypes of simple carcinomas is different from each other and few [tubular type (n = 2), tubulopapillary type (n = 1), papillary type (8) and cystic papillary type (n = 4)], there is no statistically significant difference between the gradings.

Discussion:  In this study, older age, terrier and mongrel breeds, and medium-sized indicate risk factors for malignancy. Likewise, the occurrence of multiple CMTs should be considered a significant risk factor for the development of malignant mammary tumors. Tumor localization and grading in dogs of various ages and breeds in CMTs were updated and examined in detail in the study.

Keywords: bitch, neoplasm, tumor type, grading scores, malignancy, myoepithelial cells, metastases, mammary lobes.

Downloads

Não há dados estatísticos.

Referências

Akiyoshi T., Uchida K. & Tateyama S. 2004. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors. Veterinary Pathology. 41: 154-63. DOI: 10.1354/vp.41-2-154 DOI: https://doi.org/10.1354/vp.41-2-154

Atalay Vural S. & Aydin Y. 2001. Ankara’da 1973-1998 yılları arasında incelenen köpek meme tümörleri. Turkish Journal of Veterinary & Animal Sciences. 25: 233-239.

Burrai G.P., Gabrieli A., Moccia V., Zappulli V., Porcellato I., Brachelente C., Pirino S., Polinas M. & Antuofermo E. 2020. A statistical analysis of risk factors and biological behavior in canine mammary tumors: a multicenter study. Animal. 10: 1687. DOI:10.3390/ani10091687 DOI: https://doi.org/10.3390/ani10091687

Carmo Silva H., Oliveira A.R., Santos Horta R., Merísio A.C.R, Sena B.V., Souza M.C.C. & Flecher M.C. 2019. Epidemiology of canine mammary gland tumors in Espírito Santo, Brazil. Acta Scientiae Veterinariae. 47. DOI: 10.22456/1679-9216.89901 DOI: https://doi.org/10.22456/1679-9216.89901

Devarathnam J., Suresh Kumar R.V., Bharathi S. & Anand Kumar A. 2021. Epidemiological studies of canine mammary gland tumors. Pharma Innovation. 10: 13-17.

Elston C.W. 1987. Grading of invasive carcinoma of the breast. In: Anderson T.J. (Ed). Diagnostic Histopathology of the Breast. London: Churchill Livingstone, pp.300-311.

Gama A., Alves A., Gartner F. & Schmitt F. 2003. p63: a novel myoepithelial cell marker in canine mammary tissues. Veterinary Pathology. 40: 412-420. DOI: 10.1354/vp.40-4-412 DOI: https://doi.org/10.1354/vp.40-4-412

Goldschmidt M.H., Peña L. & Zappulli V. 2017. Tumors of the mammary gland. In: Meuten D.J. (Ed). Tumors in Domestic Animals. 5th edn. Ames: Wiley Blackwell, pp.723-765. DOI: https://doi.org/10.1002/9781119181200.ch17

Im K.S., Kim N.H., Lim H.Y., Kim H.W., Shin J.I. & Sur J.H. 2014. Analysis of a new histological and molecular-based classification of canine mammary neoplasia. Veterinary Pathology. 51: 549-559. DOI: 10.1177/0300985813498780 DOI: https://doi.org/10.1177/0300985813498780

Kumar P. & Parasar M.C. 2020. Occurrence of mammary tumor in dogs. Journal of Agricultural Research Advances. 2: 29-32.

Moulton J.E. 1990. Tumors of the mammary gland. In: Moulton J.E. (Ed). Tumors in Domestic Animals. Berkeley: University Press, pp.518-552.

Muhammadnejad A., Keyhani E., Mortazavi P., Behjati F. & Haghdoost I.S. 2012. Overexpression of HER-2/neu in malignant mammary tumors; translation of clinicopathological features from dog to human. Asian Pacific Journal of Cancer Prevention. 13: 6415-6421. DOI: 10.7314/apjcp.2012.13.12.6415. DOI: https://doi.org/10.7314/APJCP.2012.13.12.6415

Nunes F.C., Campos C.B., Teixeira S.V., Bertagnolli A.C., Lavalle G.E. & Cassali G.D. 2018. Epidemiological, clinical and pathological evaluation of overall survival in canines with mammary neoplasms. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia. 70: 1714-1722. DOI: 10.1590/1678-4162-10217. DOI: https://doi.org/10.1590/1678-4162-10217

Pastor N., Caballé N.C., Santella M., Ezquerra L.J., Tarazona R. & Duran E. 2018. Epidemiological study of canine mammary tumors: age, breed, size and malignancy. Austral Journal of Veterinary Sciences. 50: 143-147. DOI: 10.4067/S0719-81322018000300143. DOI: https://doi.org/10.4067/S0719-81322018000300143

Patel M.P., Ghodasara D.J., Raval S.H. & Joshi B.P. 2019. Incidence, gross morphology, histopathology and immunohistochemistry of canine mammary tumors. Indian Journal of Veterinary Science and Biotechnology. 14: 40-44. DOI: 10.21887/ijvsbt.14.4.11. DOI: https://doi.org/10.21887/ijvsbt.14.4.11

Peña L., Andrés P.J., Clemente M., Cuesta P. & Pérez-Alenza M.D. 2013. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Veterinary Pathology. 50: 94-105. DOI: 10.1177/0300985812447830. DOI: https://doi.org/10.1177/0300985812447830

Rasotto R., Berlato D., Goldschmidt M.H. & Zappulli V. 2017. Prognostic significance of canine mammary tumor histologic subtypes: an observational cohort study of 229 cases. Veterinary Pathology. 54: 571-578. DOI: 10.1177/0300985817698208. DOI: https://doi.org/10.1177/0300985817698208

Rodríguez J., Santana Á., Herráez P., Killick D.R. & de Los Monteros A.E., 2022. Epidemiology of canine mammary tumours on the Canary Archipelago in Spain. BMC Veterinary Research. 18: 1-14. DOI: 10.1186/s12917-022-03363-9. DOI: https://doi.org/10.1186/s12917-022-03363-9

Sarkar A., Ray K., Basu S., Jha A.K., Mandal A., Mandal D., Sarkar P., Kumar K. & Datta S. 2022. Clinico-pathological studies on canine mammary tumors in dachshund dog. Indian Journal of Animal Research. 56: 336-341. DOI: 10.18805/IJAR.B-4271 DOI: https://doi.org/10.18805/IJAR.B-4271

Sontas B.H., Ozyogurtcu H., Gurel A. & Ekici H. 2009. Evaluation of clinical and pathological characteristics of 155 canines with mammary tumours: a retrospective study. Archivos de Medicina Veterinaria. 41: 53-59. DOI: 10.4067/S0301-732X2009000100007 DOI: https://doi.org/10.4067/S0301-732X2009000100007

Sorenmo K.U., Kristiansen V.M., Cofone M.A., Shofer F.S., Breen A.M., Langeland M., Mongil C.M., Grondahl A.M., Teige J. & Goldschmidt M.H. 2009. Canine mammary gland tumors; a histological continuum from benign to malignant; clinical and histopathological evidence. Veterinary and Comparative Oncology. 7: 162-172. DOI: 10.1111/j.1476-5829.2009.00184.x. DOI: https://doi.org/10.1111/j.1476-5829.2009.00184.x

Sorenmo K.U., Rasotto R., Zappulli V. & Goldschmidt M.H. 2011. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Veterinary Pathology. 48: 85-97. DOI: 10.1177/0300985810389480. DOI: https://doi.org/10.1177/0300985810389480

Sorenmo K.U., Worley D.R. & Zappulli V. 2020. Tumors of the mammary gland. In: Withrow S.J., Vail D.V., Thamm D.H. & Liptak J.M. (Eds). Withrow & MacEwen’s small animal clinical oncology. 6th edn. St. Louis: Elsevier, pp.604-615. DOI: https://doi.org/10.1016/B978-0-323-59496-7.00028-1

Varney D., O'Neill D., O'Neill M., Church D., Stell A., Beck S., Smalley M.J. & Brodbelt D. 2023. Epidemiology of mammary tumors in bitches under veterinary care in the UK in 2016. Veterinary Record: e3054. DOI: 10.1002/vetr.3054. DOI: https://doi.org/10.1002/vetr.3054

Vos J.H., van Den Ingh T.S.G.A.M., Misdrop W., Molenbeek R.F., van Mil F.N., Rutteman G.R., Ivanyi D. & Ramaekers F.C.S. 1993. Immunohistochemistry with keratin, vimentin, desmin, and alpha smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumors. The Veterinary Quarterly. 15: 96-102. DOI: 10.1080/01652176.1993.9694382. DOI: https://doi.org/10.1080/01652176.1993.9694382

Zheng H.H., Du C.T., Yu C., Zhang Y.Z., Huang R.L., Tang X.Y. & Xie G.H. 2022. Epidemiological investigation of canine mammary tumors in Mainland China between 2017 and 2021. Frontiers in Veterinary Science. 9: 843390. DOI: 10.3389/fvets.2022.843390. DOI: https://doi.org/10.3389/fvets.2022.843390

Arquivos adicionais

Publicado

2024-04-04

Como Citar

tunc, arda selin, & Sevil Atalay Vural. (2024). Canine Mammary Tumors - Breed, Age and Malignant Characteristics as Risk Factors. Acta Scientiae Veterinariae, 52(1). https://doi.org/10.22456/1679-9216.134166

Edição

Seção

Articles